Using advanced computer tools to discover new cancer drugs.
A Multi-pronged Computational Approach to Advance Kinase Drug Discovery
This study is working on new ways to design better cancer drugs that target specific proteins called kinases, which could help create more effective treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10819478 on NIH RePORTER |
What this research studies
This research focuses on developing innovative computational methods to enhance the design of drugs targeting kinases, which are crucial in cancer treatment. By utilizing advanced molecular simulations and quantum calculations, the project aims to identify new druggable sites and improve the effectiveness of reversible and targeted covalent inhibitors. Patients may benefit from the insights gained in this research, as it could lead to the development of more effective cancer therapies. The research will also explore the mechanisms that govern the selectivity and kinetics of these inhibitors, ultimately aiming to accelerate the drug discovery process.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancers that are driven by kinase activity and may benefit from new targeted therapies.
Not a fit: Patients with cancers that do not involve kinase deregulation may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and targeted cancer treatments.
How similar studies have performed: Other research has shown success in using computational approaches for drug discovery, indicating that this method has potential for significant advancements.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Shen, Jana — University of Maryland Baltimore
- Study coordinator: Shen, Jana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.